76.14
Schlusskurs vom Vortag:
$69.59
Offen:
$70.935
24-Stunden-Volumen:
546.48K
Relative Volume:
0.44
Marktkapitalisierung:
$2.26B
Einnahmen:
$442.68M
Nettoeinkommen (Verlust:
$-77.81M
KGV:
-28.53
EPS:
-2.6684
Netto-Cashflow:
$-28.65M
1W Leistung:
+16.40%
1M Leistung:
+15.84%
6M Leistung:
-10.09%
1J Leistung:
-28.47%
Genedx Holdings Corp Stock (WGS) Company Profile
Firmenname
Genedx Holdings Corp
Sektor
Branche
Telefon
888-729-1206
Adresse
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, IDXX, NTRA, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
WGS
Genedx Holdings Corp
|
76.02 | 1.80B | 442.68M | -77.81M | -28.65M | -2.6684 |
|
TMO
Thermo Fisher Scientific Inc
|
587.54 | 207.93B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
203.95 | 138.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
589.31 | 43.87B | 4.45B | 1.10B | 1.06B | 13.59 |
|
NTRA
Natera Inc
|
319.10 | 36.95B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
A
Agilent Technologies Inc
|
144.80 | 38.94B | 7.23B | 1.41B | 1.09B | 4.979 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-09 | Eingeleitet | Piper Sandler | Overweight |
| 2025-05-15 | Eingeleitet | Guggenheim | Buy |
| 2025-05-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-10 | Eingeleitet | Craig Hallum | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
Alle ansehen
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
Portnoy Law Firm Announces Class Action on Behalf of GeneDX Holdings, Corp. Investors - Carroll County Mirror-Democrat
MONDAY DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead GeneDx Class Action LawsuitWGS - TMX Newsfile
GeneDx Holdings Corp (WGS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
GENEDX HOLDINGS DEADLINE AUGUST 3rd: Bragar Eagel & Squire, - GlobeNewswire
GENEDX HOLDINGS DEADLINE AUGUST 3rd: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
GeneDx Holdings Corp. (NASDAQ: WGS) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action - PR Newswire
Sema4 to Settle Investor’s AI Hype Lawsuit for $4.75 Million - Bloomberg Law News
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock DeclineInvestors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - The Globe and Mail
GeneDx Holdings Corp. (WGS) Investors: August 3, 2026, Filing Deadline in Securities Fraud Class ActionContact Kessler Topaz Meltzer & Check, LLP - NewMediaWire
WGS Shareholder Alert: August 3, 2026 Lead Plaintiff - GlobeNewswire
GeneDx Holdings Corp (WGS) Balance Sheet - TradingKey
Genedx Holdings Corp. (WGS) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
GeneDx Holdings Corp (WGS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GeneDx Holdings Corp (WGS) Valuation: PE, PB & Fair Value Analysis - TradingKey
How GeneDx’s Securities Lawsuit and Fabric Genomics Impairment Will Impact GeneDx Holdings (WGS) Investors - simplywall.st
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
WGS FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important August 3 Deadline in Securities Class Action - GlobeNewswire Inc.
GeneDx Holdings Corp (WGS) Income Statement - TradingKey
Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm - lincolnjournal.com
Class Action Alert: Levi & Korsinsky Reminds GeneDx Holdings Corp. (WGS) Investors of August 3, 2026 Deadline - ACCESS Newswire
GeneDx Holdings Corp. (WGS) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of August 3, 2026 Deadline - ACCESS Newswire
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds - The National Law Review
WGS UPCOMING DEADLINE : The Gross Law Firm Alerts GeneDx Holdings Corp. Stockholders of Securities Class ActionContact the Firm - Supply Chain Digital
WGS LAWSUIT ALERT: Levi & Korsinsky Notifies GeneDx Holdings Corp. InvestorsLead Plaintiff Deadline August 3, 2026 - ACCESS Newswire
GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp.WGS - PR Newswire
WGS 10-DAY DEADLINE ALERT: GeneDx Holdings Corp. (NASDAQ: - GlobeNewswire
AUGUST 3, 2026 WGS DEADLINE ALERT: Robbins Geller Rudman & - GlobeNewswire
INVESTOR DEADLINE ALERT: GeneDx Holdings Corp. (WGS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Morningstar
HAGENS BERMAN, SOBOL SHAPIRO LLP ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff Deadline - PR Newswire
GeneDx Holdings Corp (WGS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
WGS Deadline: Rosen Law Firm Urges GeneDx Holdings Corp. (NASDAQ: WGS) Stockholders to Contact the Firm for Information About Their Rights - The Joplin Globe
WGS DEADLINE ALERT: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- August 3, 2026 Deadline - Morningstar
GeneDx Shareholder Alert: ClaimsFiler Reminds Investors - GlobeNewswire
Lost Money on GeneDx Holdings Corp. (WGS)? Join Class Action Suit Seeking RecoveryContact SueWallSt - TradingView
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
GeneDx Holdings Corp (WGS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Trading the Move, Not the Narrative: (WGS) Edition - Stock Traders Daily
Genedx Holdings Corp. (WGS) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
WGS Deadline: WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit - Charleston Gazette-Mail
Robbins LLP Reminds WGS Investors of the Pending Class - GlobeNewswire
WGS Deadline Alert: Levi & Korsinsky Reminds GeneDx Holdings Corp. (WGS) Investors of Securities Class Action Deadline on August 3, 2026 - PR Newswire
GeneDx (WGS) Is Still Growing in Core Testing, but the Guidance Reset Changed the Story - AlphaStreet
GeneDx Holdings Corp. (WGS) warrants to be removed from Nasdaq listing - Stock Titan
INVESTOR DEADLINE ALERT: GeneDx Holdings Corp. (WGS) Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - NewMediaWire
WGS Shareholder Alert: GeneDx Holdings Corp. Securities Class Action LawsuitInvestors With Losses May Contact The Gross Law Firm - Morningstar
GeneDx Holdings Corp. (WGS) Slid as Revenue Fell Short of Expectations - Yahoo Finance
WGS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026 - marketscreener.com
WGS DEADLINE ALERT: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitAugust 3, 2026 Deadline - TMX Newsfile
GeneDx Holdings Corp. (WGS) Stock Analysis: A 34.84% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Class Action Filed Against GeneDx Holdings Corp. (WGS) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
WGS DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, - GlobeNewswire
Finanzdaten der Genedx Holdings Corp-Aktie (WGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Genedx Holdings Corp-Aktie (WGS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| RUCH JOSHUA | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
33,299 |
| PFENNIGER RICHARD C JR | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
45,082 |
| Meister Keith A. | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
23,705 |
| Leproust Emily M. | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
24,852 |
| Casdin Eli | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
24,093 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jun 16 '26 |
Option Exercise |
0.00 |
7,197 |
0 |
43,683 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jun 16 '26 |
Sale |
60.77 |
3,729 |
226,597 |
39,954 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Jun 16 '26 |
Option Exercise |
0.00 |
18,750 |
0 |
114,873 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Jun 16 '26 |
Sale |
60.77 |
10,501 |
638,104 |
104,372 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jun 09 '26 |
Option Exercise |
0.00 |
2,462 |
0 |
37,752 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):